EUVIMEDEUVIMED entdecken
Crossref

Maxing Shigan decoction serves as a key component of Lianhua Qingwen in alleviating lung and gut injury by restoring gut microbiota homeostasis and inhibiting inflammation via TLR4/NF-κB and JAK2/STAT3 dual regulation

Caiyun Yuan, Peipei Jin, Zhuo He, Jing Guo, Mingyu Xiong, Jiemeng Sun, Le Wang, Zixuan Wang, Ningxin Han, Wei Feng, Yunlong Hou, Hui Qi und 1 weitere

Microbial Pathogenesis · 2026

DOI: 10.1016/j.micpath.2026.108285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Caiyun Yuan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050091, Hebei, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Gastrointestinal Microbiome, Acute Lung Injury, Inflammation. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, Hebei Province Science and Technology Support Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalGastrointestinal MicrobiomeAcute Lung InjuryInflammationAnimalsToll-Like Receptor 4Janus Kinase 2STAT3 Transcription FactorNF-kappa BMaleHomeostasisSignal TransductionMiceLungColitis, UlcerativeCytokinesMice, Inbred C57BLDisease Models, AnimalIntestinal Barrier FunctionLipopolysaccharides

Stichwörter der Autor:innen

Acute Lung injuryGut-Lung axisLianhua Qingwen CapsulesMaxing-Shigan DecoctionMicrobiotaUlcerative colitis

Substanzen

Drugs, Chinese HerbalToll-Like Receptor 4Janus Kinase 2STAT3 Transcription FactorNF-kappa BlianhuaqingwenCytokinesTlr4 protein, mouseStat3 protein, mouseLipopolysaccharides

Autor:innen und Institutionen

  • Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050091, Hebei, China.
  • Hebei Yiling Hospital, High-level TCM Key Disciplines of National Administration of Traditional Chinese Medicine-Luobing Theory, Shijiazhuang, 050091, Hebei, China.
  • Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050091, Hebei, China; The First Hospital of Hebei University of Chinese Medicine, Shijiazhuang, 050011, Hebei, China.
  • Graduate School, Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
  • Hebei Luoxue Innovation Medical Research Institute, Shijiazhuang, 050091, Hebei, China; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, 050035, Hebei, China.
  • Hebei Luoxue Innovation Medical Research Institute, Shijiazhuang, 050091, Hebei, China; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, 050035, Hebei, China; Shanghai Yiling Pharm…

Förderung

  • Natural Science Foundation of Hebei Province
  • Hebei Province Science and Technology Support Program
  • National Natural Science Foundation of China

Zitieren

APA

Yuan, C., Jin, P., He, Z., Guo, J., Xiong, M., Sun, J., Wang, L., Wang, Z., Han, N., Feng, W., Hou, Y., Qi, H., & Jia, Z. (2026). Maxing Shigan decoction serves as a key component of Lianhua Qingwen in alleviating lung and gut injury by restoring gut microbiota homeostasis and inhibiting inflammation via TLR4/NF-κB and JAK2/STAT3 dual regulation. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108285

Vancouver

Yuan C, Jin P, He Z, Guo J, Xiong M, Sun J, et al. Maxing Shigan decoction serves as a key component of Lianhua Qingwen in alleviating lung and gut injury by restoring gut microbiota homeostasis and inhibiting inflammation via TLR4/NF-κB and JAK2/STAT3 dual regulation. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108285

BibTeX
@article{Yuan2026,
  author = {Yuan, Caiyun and Jin, Peipei and He, Zhuo and Guo, Jing and Xiong, Mingyu and Sun, Jiemeng and Wang, Le and Wang, Zixuan and Han, Ningxin and Feng, Wei and Hou, Yunlong and Qi, Hui and Jia, Zhenhua},
  title = {Maxing Shigan decoction serves as a key component of Lianhua Qingwen in alleviating lung and gut injury by restoring gut microbiota homeostasis and inhibiting inflammation via TLR4/NF-κB and JAK2/STAT3 dual regulation},
  journal = {Microbial Pathogenesis},
  year = {2026},
  doi = {10.1016/j.micpath.2026.108285}
}
Kostenlos starten →